http://www.ft.com/companies/healthhttp://www.ft.com/rss/companies/healthFT.com - Healthen© Copyright The Financial Times Ltd 2009. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.client.support@ft.com (Client Support)Wed, 11 Nov 2009 18:07:07 +0000Wed, 11 Nov 2009 18:48:13 +0000Newspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gifhttp://www.ft.com/companies/health(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://traxfer.ft.com/cms/s/0/f0de49a6-ceeb-11de-8a4b-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/f0de49a6-ceeb-11de-8a4b-00144feabdc0.htmlCompensation is shrinking faster for senior managers of UK companies in the recession than for board members, according to a report by DeloitteWed, 11 Nov 2009 18:07:07 +0000http://traxfer.ft.com/cms/s/0/21454032-cd24-11de-a748-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/21454032-cd24-11de-a748-00144feabdc0.htmlPrivate equity groups triumphed over several industrial groups – including Alliance Boots – in the $858m auction of Sweden's state-owned pharmacy chainMon, 9 Nov 2009 21:22:50 +0000http://traxfer.ft.com/cms/s/0/310b29a4-cd11-11de-a748-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/310b29a4-cd11-11de-a748-00144feabdc0.htmlThe Swiss hearing aid manufacturer has made an agreed $489m cash offer for Advanced Bionics of the US, in a renewed push for global sales dominance Mon, 9 Nov 2009 11:35:53 +0000http://traxfer.ft.com/cms/s/0/711ffdfe-ca95-11de-97e0-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/711ffdfe-ca95-11de-97e0-00144feabdc0.htmlThe prescription-drug data provider has agreed to sell itself to TPG Capital and Canada Pension Plan's investment board in what is the biggest such deal this yearFri, 6 Nov 2009 05:55:00 +0000http://traxfer.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.htmlA full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next yearFri, 6 Nov 2009 05:14:54 +0000http://traxfer.ft.com/cms/s/0/586790b0-ca2c-11de-a3a3-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/586790b0-ca2c-11de-a3a3-00144feabdc0.htmlThe drugstore and benefit management company saw its shares fall more than 20 per cent after it announced the loss of $3.7bn of prescription management contracts for 2010Thu, 5 Nov 2009 18:19:07 +0000http://traxfer.ft.com/cms/s/0/959437ac-c94d-11de-b551-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/959437ac-c94d-11de-b551-00144feabdc0.htmlThe interactive healthcare software maker reports a 59% increase in revenues to £4.2m due to gains from its computer program designed to treat depressionThu, 5 Nov 2009 00:46:04 +0000http://traxfer.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.htmlWith a smaller slice of a shrinking domestic pie, Japanese pharmaceutical companies have had to take the fight abroad. The country's track record outside manufacturing does not bode well, but it is too soon to dismiss the industry, writes David Pilling Wed, 4 Nov 2009 20:04:13 +0000http://traxfer.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.htmlThe head of the pioneering tie-up between GlaxoSmithKline and Pfizer predicts the company can operate for at least five years without new funding from shareholdersTue, 3 Nov 2009 22:52:55 +0000http://traxfer.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.htmlJohnson & Johnson will cut up to 7% of its 117,000 employees by 2011 as it reduces costs in an effort to weather the global downturn and increase spending on new products.Tue, 3 Nov 2009 21:39:51 +0000http://traxfer.ft.com/cms/s/0/a92b488c-c704-11de-bb6f-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/a92b488c-c704-11de-bb6f-00144feab49a.htmlJeffrey Kindler, chief executive of Pfizer, expressed confidence that US healthcare reform would be approved by the end of this year, and praised the Senate finance committee's latest draft in spite of the extra costs it would impose on his businessSun, 1 Nov 2009 17:58:00 +0000http://traxfer.ft.com/cms/s/0/e23cc0ac-c573-11de-8193-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/e23cc0ac-c573-11de-8193-00144feab49a.htmlFalling sales of its now off-patent drug Adderall XR continue to weigh on the speciality pharmaceutical group, although strong growth in sales of new drugs are poised to compensateFri, 30 Oct 2009 20:46:02 +0000http://traxfer.ft.com/cms/s/0/512a0bac-c4af-11de-8d54-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/512a0bac-c4af-11de-8d54-00144feab49a.htmlAstraZeneca is poised to pay more than $500m to settle allegations in the US of marketing abuses of its second-most important drugThu, 29 Oct 2009 17:57:16 +0000http://traxfer.ft.com/cms/s/0/edc1bde2-c3fc-11de-8de6-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/edc1bde2-c3fc-11de-8de6-00144feab49a.htmlThe group's traditional core market of prescription medicines in developed countries may fall to just a quarter of total sales according to Andrew Witty, chief executive of GSKWed, 28 Oct 2009 20:43:37 +0000http://traxfer.ft.com/cms/s/0/606d4184-c3b9-11de-a290-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/606d4184-c3b9-11de-a290-00144feab49a.htmlStrong growth in emerging markets and Japan, and in consumer healthcare products, offset declines in US pharmaceuticals, but the drugs group expects strong sales of flu vaccineWed, 28 Oct 2009 13:28:26 +0000